O-Desethyl Dapagliflozin (Empagliflozin-4) is an active metabolite and potent SGLT2 inhibitor with an IC50 of 33 nM. It is a valuable reference compound for pharmacokinetic and metabolic studies in diabetes research, applicable in both in vitro enzymatic assays and in vivo models.